These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18294468)

  • 21. Integrity of stent polymer layer after drug-eluting stent implantation: in vivo comparison of sirolimus-, paclitaxel-, zotarolimus- and everolimus-eluting stents.
    Watanabe T; Fujita M; Awata M; Iida O; Okamoto S; Ishihara T; Uematsu M
    Cardiovasc Interv Ther; 2014 Jan; 29(1):4-10. PubMed ID: 23818255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).
    Tsuchiya Y; Lansky AJ; Costa RA; Mehran R; Pietras C; Shimada Y; Sonoda S; Cristea E; Negoita M; Dangas GD; Moses JW; Leon MB; Fitzgerald PJ; Müller R; Störger H; Hauptmann KE; Grube E
    Am J Cardiol; 2006 Aug; 98(4):464-9. PubMed ID: 16893698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sirolimus- and taxol-eluting stents differ towards intimal hyperplasia and re-endothelialization.
    Liuzzo JP; Ambrose JA; Coppola JT
    J Invasive Cardiol; 2005 Sep; 17(9):497-502. PubMed ID: 16145242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and angiographic outcomes after overdilatation of undersized sirolimus-eluting stents with largely oversized balloons: an observational study.
    Saia F; Lemos PA; Arampatzis CA; Hoye A; McFadden E; Sianos G; Smits PC; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Catheter Cardiovasc Interv; 2004 Apr; 61(4):455-60. PubMed ID: 15065137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of sirolimus-eluting stent implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance.
    Seung KB; Kim YH; Park DW; Lee BK; Lee CW; Hong MK; Kim PJ; Chung WS; Tahk SJ; Park SW; Park SJ
    J Am Coll Cardiol; 2005 Sep; 46(5):787-92. PubMed ID: 16139126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-eluting stents for the prevention of restenosis: Standing the test of time.
    Carter AJ
    Catheter Cardiovasc Interv; 2002 Sep; 57(1):69-71. PubMed ID: 12203932
    [No Abstract]   [Full Text] [Related]  

  • 27. Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation.
    Gao RL; Xu B; Chen JL; Yang YJ; Qiao SB; Li JJ; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J
    Am Heart J; 2008 Mar; 155(3):553-61. PubMed ID: 18294496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis.
    Habara S; Mitsudo K; Goto T; Kadota K; Fujii S; Yamamoto H; Kato H; Takenaka S; Fuku Y; Hosogi S; Hirono A; Yamamoto K; Tanaka H; Hasegawa D; Nakamura Y; Tasaka H; Otsuru S; Okamoto Y; Yamada C; Miyamoto M; Inoue K
    Heart; 2008 Sep; 94(9):1162-5. PubMed ID: 18032460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound.
    Kimura M; Mintz GS; Carlier S; Takebayashi H; Fujii K; Sano K; Yasuda T; Costa RA; Costa JR; Quen J; Tanaka K; Lui J; Weisz G; Moussa I; Dangas G; Mehran R; Lansky AJ; Kreps EM; Collins M; Stone GW; Moses JW; Leon MB
    Am J Cardiol; 2006 Aug; 98(4):436-42. PubMed ID: 16893693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sirolimus-eluting coronary stents: a review.
    Abizaid A
    Vasc Health Risk Manag; 2007; 3(2):191-201. PubMed ID: 17580729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restenosis treatment in the drug-eluting stent era.
    Presbitero P; Boccuzzi G
    Ital Heart J; 2005 Jun; 6(6):514-21. PubMed ID: 16008157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of "Cypher" sirolimus-eluting stents in coronary heart disease patients with different types of coronary arterial lesions].
    Belenkov IuN; Matchin IuG; Liakishev AA; Savchenko AP
    Vestn Rentgenol Radiol; 2006; (3):4-12. PubMed ID: 17407958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of everolimus-eluting stent with a bioresorbable polymer coating for treatment of recurrent in-stent restenosis.
    Honda H; Meguro T; Takizawa K; Isoyama S
    J Invasive Cardiol; 2005 Feb; 17(2):112-5. PubMed ID: 15687539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases.
    Lemos PA; Saia F; Ligthart JM; Arampatzis CA; Sianos G; Tanabe K; Hoye A; Degertekin M; Daemen J; McFadden E; Hofma S; Smits PC; de Feyter P; van der Giessen WJ; van Domburg RT; Serruys PW
    Circulation; 2003 Jul; 108(3):257-60. PubMed ID: 12860901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IMPACT Trial: angiographic and intravascular ultrasound observations of the first human experience with mycophenolic acid-eluting polymer stent system.
    Abizaid A; Albertal M; Ormiston J; Londero H; Ruygrok P; Seixas AC; Feres F; Mattos LA; Staico R; Silva RL; Webster M; Stewart J; Paoletti F; Kataoka T; Fitzgerald P; Sousa A; Sousa JE
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):491-5. PubMed ID: 16283680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is sirolimus better than paclitaxel? A review of the comparative data on drug-eluting stents.
    Corbett SJ; Babic R; Cosgrave J; Sangiorgi GM; Colombo A
    Cardiovasc Revasc Med; 2006; 7(3):159-64. PubMed ID: 16945823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five-year clinical follow-up after sirolimus-eluting stent implantation for the treatment of coronary in-stent restenosis.
    Schiele TM; Leibig M; Rieber J; König A; Krötz F; Sohn HY; Klauss V
    Coron Artery Dis; 2011 May; 22(3):188-93. PubMed ID: 21394029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravascular ultrasound-guided high-pressure balloon predilatation for optimal drug-eluting stent deployment in restenosis of a stent implanted 7 years earlier. Do we know the right technique for in-stent restenosis restenting?
    Kalińczuk L; Demkow M; Ruzyłło W
    J Invasive Cardiol; 2008 May; 20(5):E139-45. PubMed ID: 18460715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiographic and volumetric intravascular ultrasound comparison between direct sirolimus-eluting stent implantation versus predilation.
    Muñoz JS; Abizaid A; Albertal M; Mintz GS; Graebin R; Feres F; Staico R; Mattos LA; Tanajura LF; Abizaid AS; Sousa A; Sousa JE
    Am J Cardiol; 2004 Jun; 93(12):1522-5. PubMed ID: 15194025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.